Compound Profile: GW-501516 (Cardarine) Pharmaqo
GW-501516 is a peroxisome proliferator-activated receptor delta (PPARδ) agonist developed for metabolic research applications. This compound modulates fatty acid oxidation and energy expenditure pathways in preclinical models, making it valuable for researchers investigating cellular metabolism. Originally developed by GlaxoSmithKline, this molecular entity demonstrates significant activity at the PPARδ receptor with established binding affinity. The compound’s mechanism involves activation of genes responsible for fatty acid catabolism and mitochondrial biogenesis. Researchers studying metabolic disorders frequently examine this compound’s effects on cellular energy utilisation. Available through Stroid UK Shop, this research-grade material enables detailed investigation of PPARδ pathway modulation.
Laboratory Research Applications
Investigators utilise GW-501516 to study peroxisome proliferator-activated receptor signalling in cellular metabolism research. The compound allows researchers to examine fatty acid oxidation enhancement and mitochondrial function modulation in controlled laboratory environments. Studies investigating metabolic syndrome models frequently incorporate this PPARδ agonist to evaluate energy expenditure pathways. Research teams examining circadian metabolism patterns analyse how PPARδ activation influences cellular energy homeostasis. Available in the broader Endurobol research category, this compound supports comprehensive metabolic investigations. Cellular bioenergetics researchers study the compound’s effects on substrate utilisation and oxygen consumption rates. Scientists investigating diabetes models examine PPARδ pathway activation as a potential therapeutic target. Laboratories studying exercise mimetics analyse this compound’s capacity to enhance oxidative metabolism. Research applications extend to cardiovascular metabolism studies and adipose tissue function investigations. Teams working with selective androgen receptor modulators often include metabolic modulators like GW-501516 in comparative studies. The compound enables detailed examination of nuclear receptor signalling pathways and their downstream metabolic effects. Researchers studying aging and metabolic decline frequently incorporate this PPARδ agonist into their experimental protocols.
Chemical Specifications
| Property | Value |
|---|---|
| Chemical Name | GW-501516 (Cardarine) |
| CAS Number | 317318-70-0 |
| Molecular Formula | C₂₁H₁₈F₃NO₃S₂ |
| Molecular Weight | 453.50 g/mol |
| Compound Class | PPARδ Receptor Agonist |
| Storage Requirements | Room temperature, protect from light |
| Manufacturer | Pharmaqo |
Research Compliance Statement
This GW-501516 research compound is manufactured exclusively for in-vitro scientific research and laboratory analysis. The product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with relevant institutional guidelines and regulatory frameworks when conducting studies with this material. The compound should be handled only by qualified laboratory personnel with appropriate training in chemical safety protocols. Research teams incorporating metabolic modulators alongside peptide research compounds must maintain proper documentation and adherence to laboratory safety standards. All experimental work must be conducted within approved research facilities with adequate ventilation and safety equipment. This product is supplied for legitimate scientific research purposes only and requires appropriate institutional oversight for all investigational activities.
